@article{fc328269c1eb4d04840f0d4605116d3c,
title = "Reply: How should coronary computed tomography angiography co-registration be applied in the chronic total occlusion hybrid algorithm?",
author = "Iosif Xenogiannis and Brilakis, {Emmanouil S.}",
note = "Funding Information: E. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens; is the owner of Hippocrates LLC and a shareholder of MHI Ventures. I. Xenogiannis has no conflicts of interest to declare.",
year = "2021",
doi = "10.4244/EIJ-D-20-00924R",
language = "English (US)",
volume = "16",
pages = "1374--1375",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "16",
}